(A) IMR-90 human fetal lung fibroblasts were transduced with pBabe or myrAKT1. On day 5 post-transduction, cells were transfected with either CBS siRNA (siCBS) or control siRNA (siOTP). Western blot analysis was performed on day 6 post-siRNA transfection. Actin was probed as a loading control. Representative of n=3 experiments. (B) BJ3 human skin fibroblasts expressing telomerase reverse transcriptase (BJ-TERT) human skin fibroblasts and human mammary epithelial cells (HMEC) were transduced with either pBabe or AKT1E17K. Western blot analysis was performed on day 14 post-transduction. Vinculin was probed as a loading control. (C) BJ-TERT cells were transduced with pBabe, myrAKT1, and HRASG12V. Relative CBS mRNA expression measured on day 14 post-transduction by qPCR was normalized to pBabe control are presented as mean ± SEM (n=3). One sample t-test compared to the hypothetical value 1.0 was performed (NS, not significant). (D) BJ-TERT cells were transduced with pBabe, myrAKT1, and HRASG12V and then treated with aminoxyacetate (AOAA) 30 μM or vehicle (DMSO) on day 5 post-transduction. The percentage of cells with positive staining for SA-βGal activity was quantified on day 6 post-treatment and presented as mean ± SD (n=2). Two-way analysis of variance (ANOVA) with Holm-Šídák multiple comparisons was performed (NS, not significant).
Figure 1—figure supplement 1—source data 1. Unedited immunoblots of Figure 1—figure supplement 1B.Raw images were acquired using the ChemiDoc system (Bio-Rad).